STAND. COM. REP. NO. 736
Honolulu, Hawaii
, 2005
RE: H.B. No. 32
H.D. 2
Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twenty-Third State Legislature
Regular Session of 2005
State of Hawaii
Sir:
Your Committee on Finance, to which was referred H.B. No. 32, H.D. 2, entitled:
"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUG COST CONTAINMENT AND AFFORDABLE ACCESS,"
begs leave to report as follows:
The purpose of this bill is to:
(1) Establish measures to control the rising cost of prescription drugs;
(2) Allow any public or private health plan to participate in the cost controlling measures;
(3) Establish a prescription drug preferred list and a prior authorization review process; and
(4) Require drug manufactures to disclose economic benefits of $25 or more given to those who prescribe, dispense, or purchase prescription drugs.
AARP Hawaii, Kokua Council, and a pair of concerned individuals supported this bill. ILWU Local 142 supported the concept of this measure. The Department of Human Services and Pharmaceutical Research and Manufacturers of America opposed this bill. The Office of Informational Practices and Hawaii Medical Service Association provided comments on this measure.
As affirmed by the record of votes of the members of your Committee on Finance that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 32, H.D. 2, and recommends that it pass Third Reading.
Respectfully submitted on behalf of the members of the Committee on Finance,
|
____________________________ DWIGHT TAKAMINE, Chair |
||